Parkinson's disease (PD) is a neurodegenerative disorder that primarily affects middle-aged and elderly individuals, ranking second only to Alzheimer's disease. Currently, traditional medications have limited effectiveness in treating PD. Replacing or compensating for the damaged dopaminergic neurons with healthy ones through brain implantation may offer potential treatment or even cure for Parkinson's disease.

Diabetes mellitus (DM) is a metabolic disorder characterized by varying degrees of insulin deficiency or pancreatic dysfunction. Islet cell replacement therapy has the potential to become the most promising method to "end" insulin injections.

Through super donor iPSC+ gene modification technology, Nuwacell Biotechnologies Co., Ltd. can break through the limitations of cell quantity and reduce immunogenicity, providing high purity, batch-to-batch consistency, and stable quality iPSC-derived imDAP and islets cell preparations.